通过GDMPredictor提高妊娠糖尿病风险评估和治疗:一种机器学习方法
J Xing1,2, K Dong1,2, X Liu1,2
1Department of Laboratory Medicine, The Third Affiliated Hospital of Zhengzhou University, 7 Kangfu Qian Street, Zhengzhou, 450052, Henan, People's Republic of China.
Journal of endocrinological investigation
|March 9, 2024
概括
一个新的工具,GDMPredictor,使用机器学习准确预测孕妇妊娠期糖尿病 (GDM) 风险. 早期检测和个性化治疗建议可以改善母亲和胎儿的健康结果.
科学领域:
- 医疗信息学 医疗信息学
- 医疗保健中的机器学习
- 生殖健康 生殖健康
背景情况:
- 孕期糖尿病 (GDM) 对孕妇构成全球健康风险,可能导致不良后果.
- 早期识别和及时干预对于改善GDM病例的妊娠结果至关重要.
研究的目的:
- 开发和验证GDMPredictor,一个利用机器学习预测GDM风险的Web服务器.
- 根据生化指标,为孕妇个性化治疗策略.
主要方法:
- 在培训中使用了3467名孕妇和5649名临床/生化记录的队列.
- 机器学习算法被用来构建GDMPredictor网络服务器.
- 用曲线下的面积 (AUC) 和精度回忆曲线下的面积 (auPRC) 来评估模型性能.
主要成果:
- GDMPredictor实现了高预测准确性,其AUC得分为0.967.
- 该工具可以使用生物化学指标预测妊娠1至24周的GDM风险.
- 风险分层使高风险个体能够获得个性化,密集的护理.
结论:
- GDMPredictor为临床实践提供了一种有价值的工具,有可能改变GDM管理.
- 高精度和高效率的GDMPredictor支持改善患者的治疗结果.
- 早期GDM检测和量身定制的治疗可以改善母亲和胎儿的健康.
相关概念视频
Diabetes Mellitus: Type 2 and Gestational
2.4K
Type 2 diabetes, characterized by insulin resistance, arises when the insulin receptors on cells lose responsiveness to insulin, diminishing the cell's capacity to take up glucose, resulting in elevated blood glucose levels. To receive a diagnosis of Type 2 diabetes, a series of blood glucose tests are necessary to assess whether the blood glucose falls within normal parameters. If the result is out of the normal range, a patient may be diagnosed as prediabetic or diabetic, depending on the...
2.4K
Pathophysiology of Diabetes
928
Diabetes mellitus is a chronic metabolic disorder characterized by hyperglycemia. The four categories of diabetes are type 1 diabetes, type 2 diabetes, other specific types of diabetes, and gestational diabetes.
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
Type 1 diabetes is characterized by autoimmune-mediated destruction of pancreatic β cells, with environmental factors potentially triggering this process in genetically susceptible individuals. Despite many not having a family history, certain genes increase susceptibility,...
928
Diabetes: Symptoms, Diagnosis, and Complications
534
For most patients, experiencing several weeks of polyuria, polydipsia, fatigue, and significant weight loss may indicate the presence of diabetes. Furthermore, adults displaying the phenotypic appearance of type 2 diabetes (particularly those who are obese and not initially insulin-requiring), may have islet cell autoantibodies, suggesting autoimmune-mediated β cell destruction and a diagnosis of latent autoimmune diabetes of adults (LADA). The categorization of glucose homeostasis is...
534
Dipeptidyl Peptidase 4 Inhibitors
186
Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
186
Diabetes Mellitus: Overview and Type I Subtype
2.6K
Diabetes mellitus is a chronic metabolic disorder characterized by high blood glucose levels due to inadequate insulin production, insulin resistance, or both. The condition affects millions worldwide and can significantly impact their health and quality of life.
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
2.6K
Diabetes: Management and Pharmacotherapy
282
The therapy for diabetes aims to alleviate hyperglycemia-related symptoms, prevent acute metabolic decompensation, and reduce chronic end-organ complications. Glycemic control is evaluated through short-term (self-monitoring, continuous glucose monitoring) and long-term (A1c, fructosamine) metrics, enabling near real-time tracking of blood glucose levels and reflecting glycemic control over specific time frames.
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
Insulin remains the cornerstone of treatment for most patients with type 1 and many...
282


